Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 21 -30 of 445 Show results per page	View Search Criteria \| Help With Results

Last Modified: 7/11/2007 First Published: 7/1/1997


21.		Phase III Randomized Study to Assess Intensification of the Conditioning Regimen for Allogeneic and Autologous Stem Cell Transplantation for Leukemia or Myelodysplastic Syndrome with A High Risk of Relapse (Summary Last Modified 06/2002)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				16 to 60								EORTC-06962 NCT00002989

Last Modified: 11/28/2006 First Published: 4/1/1998


22.		Phase III Randomized Study of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Sequential High-Dose Chemotherapy With Autologous Peripheral Blood Stem Cell Transplantation in Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 to 60				Other				SWS-SAKK-38/97 EU-97037, NCT00003215

Last Modified: 1/18/2008 First Published: 9/1/1998


23.		Phase III Randomized Study of Adjuvant Therapy with or without Intensification Therapy with Autologous Peripheral Blood Stem Cell Transplantation for Women with Poor Prognosis Nonmetastatic Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				Under 60								FRE-FNCLCC-PEGASE01 EU-96030

Last Modified: 5/21/2007 First Published: 12/1/1998


24.		Phase III Randomized Study of High Dose Chemotherapy and Autologous Bone Marrow Transplantation as Initial Therapy for Poor Risk Intermediate and High Grade Adult Non-Hodgkin's Lymphoma (Summary Last Modified 05/2002)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				16 to 65								BNLI-LY02 EU-98039, NCT00003578

Last Modified: 6/16/2003 First Published: 11/1/1998


25.		Phase III Randomized Study of Lomustine, Idarubicin, and Dexamethasone Versus Melphalan and Prednisolone in Patients With Multiple Myeloma in First Relapse

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				Other				RHG-MM97 EU-98030, NCT00003603

Last Modified: 8/28/2008 First Published: 4/1/1999


26.		Phase III Randomized Study of Hyperthermic Isolated Limb Perfusion With Melphalan With or Without Tumor Necrosis Factor in Patients With Locally Advanced Extremity Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				18 and over				NCI				ACOSOG-Z0020 NCI-03-C-0137, NCT00003789, ACOSOGZ0020

Last Modified: 6/26/2003 First Published: 6/1/1999


27.		Phase III Randomized Study of High-Dose Chemotherapy and Radiotherapy Plus Autologous Bone Marrow Transplantation in Patients With Aggressive Non-Hodgkin's Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				15 to 65				Other				SNLG-NHL-V(a) EU-98032, NCT00003815

Last Modified: 6/1/2007 First Published: 8/1/1999


28.		Phase III Randomized Study of High Dose Busulfan, Melphalan, and Thiotepa Versus Cyclophosphamide, Thiotepa, and Carboplatin Followed By Autologous Peripheral Blood Stem Cell Transplantation in Patients with Node Positive Stage II or IIIA Breast Cancer (Summary Last Modified 05/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 to 65				NCI				FHCRC-1316.00 PSOC-1604, NCI-G99-1552, NCT00003972

Last Modified: 10/28/2003 First Published: 12/1/1999


29.		Phase III Study of High Dose Melphalan Followed By Peripheral Blood Stem Cell Transplantation as Standard Therapy in Patients With Symptomatic Multiple Myeloma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				Not specified				NCI				NU-97H6T NCI-G99-1632, NCT00004165

Last Modified: 10/3/2007 First Published: 1/1/2000


30.		Phase III Randomized Study of Purged Versus Unpurged Peripheral Blood Stem Cell Transplantation After Dose-Intensive Induction Chemotherapy in Patients With Newly Diagnosed High Risk Neuroblastoma or Ganglioneuroblastoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				30 and under				NCI				COG-A3973 CCG-A3973, POG-A3973, CCG-39703, FHCRC-1631.00, NCT00004188, A3973

Select All on One Page


					< Previous 1 2 3 4 5 6 Next >

| | | | | | | |

A Service of the National Cancer Institute